These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 19025795

  • 1. Stepwise accumulation of distinct genomic aberrations in a patient with progressively metastasizing ependymoma.
    Milde T, Pfister S, Korshunov A, Deubzer HE, Oehme I, Ernst A, Starzinski-Powitz A, Seitz A, Lichter P, von Deimling A, Witt O.
    Genes Chromosomes Cancer; 2009 Mar; 48(3):229-38. PubMed ID: 19025795
    [Abstract] [Full Text] [Related]

  • 2. Human ependymomas reveal frequent deletions on chromosomes 6 and 9.
    Huang B, Starostik P, Schraut H, Krauss J, Sörensen N, Roggendorf W.
    Acta Neuropathol; 2003 Oct; 106(4):357-62. PubMed ID: 12898154
    [Abstract] [Full Text] [Related]

  • 3. Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas.
    Puget S, Grill J, Valent A, Bieche I, Dantas-Barbosa C, Kauffmann A, Dessen P, Lacroix L, Geoerger B, Job B, Dirven C, Varlet P, Peyre M, Dirks PB, Sainte-Rose C, Vassal G.
    J Clin Oncol; 2009 Apr 10; 27(11):1884-92. PubMed ID: 19289631
    [Abstract] [Full Text] [Related]

  • 4. Molecular staging of intracranial ependymoma in children and adults.
    Korshunov A, Witt H, Hielscher T, Benner A, Remke M, Ryzhova M, Milde T, Bender S, Wittmann A, Schöttler A, Kulozik AE, Witt O, von Deimling A, Lichter P, Pfister S.
    J Clin Oncol; 2010 Jul 01; 28(19):3182-90. PubMed ID: 20516456
    [Abstract] [Full Text] [Related]

  • 5. Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13.
    Karakoula K, Suarez-Merino B, Ward S, Phipps KP, Harkness W, Hayward R, Thompson D, Jacques TS, Harding B, Beck J, Thomas DG, Warr TJ.
    Genes Chromosomes Cancer; 2008 Nov 01; 47(11):1005-22. PubMed ID: 18663750
    [Abstract] [Full Text] [Related]

  • 6. Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma.
    Ward S, Harding B, Wilkins P, Harkness W, Hayward R, Darling JL, Thomas DG, Warr T.
    Genes Chromosomes Cancer; 2001 Sep 01; 32(1):59-66. PubMed ID: 11477662
    [Abstract] [Full Text] [Related]

  • 7. Loss of chromosome 1 in myxopapillary ependymoma suggests a region out of chromosome 22 as critical for tumour biology: a FISH analysis of four cases on touch imprint smears.
    Tamiolakis D, Papadopoulos N, Venizelos I, Lambropoulou M, Nikolaidou S, Bolioti S, Kiziridou A, Manavis J, Alexiadis G, Simopoulos C.
    Cytopathology; 2006 Aug 01; 17(4):199-204. PubMed ID: 16879268
    [Abstract] [Full Text] [Related]

  • 8. Pediatric supratentorial ependymomas show more frequent deletions on chromosome 9 than infratentorial ependymomas: a microsatellite analysis.
    Schneider D, Monoranu CM, Huang B, Rutkowski S, Gerber NU, Krauss J, Puppe B, Roggendorf W.
    Cancer Genet Cytogenet; 2009 Jun 01; 191(2):90-6. PubMed ID: 19446744
    [Abstract] [Full Text] [Related]

  • 9. Trisomy 19 ependymoma, a newly recognized genetico-histological association, including clear cell ependymoma.
    Rousseau E, Palm T, Scaravilli F, Ruchoux MM, Figarella-Branger D, Salmon I, Ellison D, Lacroix C, Chapon F, Mikol J, Vikkula M, Godfraind C.
    Mol Cancer; 2007 Jul 12; 6():47. PubMed ID: 17626628
    [Abstract] [Full Text] [Related]

  • 10. Loss of heterozygosity on chromosome 22 in human ependymomas.
    Huang B, Starostik P, Kühl J, Tonn JC, Roggendorf W.
    Acta Neuropathol; 2002 Apr 12; 103(4):415-20. PubMed ID: 11904762
    [Abstract] [Full Text] [Related]

  • 11. Immune gene and cell enrichment is associated with a good prognosis in ependymoma.
    Donson AM, Birks DK, Barton VN, Wei Q, Kleinschmidt-Demasters BK, Handler MH, Waziri AE, Wang M, Foreman NK.
    J Immunol; 2009 Dec 01; 183(11):7428-40. PubMed ID: 19917695
    [Abstract] [Full Text] [Related]

  • 12. Molecular characterization of brain tumors.
    Boudreau CR, Liau LM.
    Clin Neurosurg; 2004 Dec 01; 51():81-90. PubMed ID: 15571131
    [No Abstract] [Full Text] [Related]

  • 13. Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2.
    Hulsebos TJ, Oskam NT, Bijleveld EH, Westerveld A, Hermsen MA, van den Ouweland AM, Hamel BC, Tijssen CC.
    Br J Cancer; 1999 Dec 01; 81(7):1150-4. PubMed ID: 10584875
    [Abstract] [Full Text] [Related]

  • 14. Metastasizing anaplastic ependymoma in an adult. Chromosomal imbalances, metabolic and gene expression profiles.
    Lopez-Gines C, Gil-Benso R, Faus C, Monleon D, Mata M, Morales JM, Cigudosa JC, Gonzalez-Darder J, Celda B, Cerda-Nicolas M.
    Histopathology; 2009 Mar 01; 54(4):500-4. PubMed ID: 19309408
    [No Abstract] [Full Text] [Related]

  • 15. Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma.
    Reardon DA, Entrekin RE, Sublett J, Ragsdale S, Li H, Boyett J, Kepner JL, Look AT.
    Genes Chromosomes Cancer; 1999 Mar 01; 24(3):230-7. PubMed ID: 10451703
    [Abstract] [Full Text] [Related]

  • 16. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
    Singh PK, Gutmann DH, Fuller CE, Newsham IF, Perry A.
    Mod Pathol; 2002 May 01; 15(5):526-31. PubMed ID: 12011257
    [Abstract] [Full Text] [Related]

  • 17. Genomic characterization of ependymomas reveals 6q loss as the most common aberration.
    Olsen TK, Gorunova L, Meling TR, Micci F, Scheie D, Due-Tønnessen B, Heim S, Brandal P.
    Oncol Rep; 2014 Aug 01; 32(2):483-90. PubMed ID: 24939246
    [Abstract] [Full Text] [Related]

  • 18. Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas.
    Monoranu CM, Huang B, Zangen IL, Rutkowski S, Vince GH, Gerber NU, Puppe B, Roggendorf W.
    Cancer Genet Cytogenet; 2008 Apr 01; 182(1):18-26. PubMed ID: 18328946
    [Abstract] [Full Text] [Related]

  • 19. Identification of novel chromosomal abnormalities and prognostic cytogenetics markers in intracranial pediatric ependymoma.
    Pezzolo A, Capra V, Raso A, Morandi F, Parodi F, Gambini C, Nozza P, Giangaspero F, Cama A, Pistoia V, Garrè ML.
    Cancer Lett; 2008 Mar 18; 261(2):235-43. PubMed ID: 18179864
    [Abstract] [Full Text] [Related]

  • 20. Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas.
    Okawa ER, Gotoh T, Manne J, Igarashi J, Fujita T, Silverman KA, Xhao H, Mosse YP, White PS, Brodeur GM.
    Oncogene; 2008 Jan 31; 27(6):803-10. PubMed ID: 17667943
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.